Know which specimen was measured
Blood, plasma, cells, and tissues are not the same biological compartment. Even if a study reports a change in a blood NAD-related marker, it does not automatically establish a corresponding change in the tissues people care about. Ask how the specimen was collected, processed, and analyzed and whether the testing method has known variability.
Distinguish biomarkers from meaningful outcomes
A higher biomarker is not itself proof of longer life, sharper thinking, or improved physical function. Researchers need clinical outcomes, appropriate comparison groups, and enough follow-up time to evaluate those claims. Marketing that moves directly from a mechanistic chart to a promise of age reversal skips the difficult part of the evidence.
Examine the study population
A small trial in healthy volunteers may not apply to older adults with complex medical conditions. If a supplement raised a laboratory marker in one context, the effect may differ elsewhere. Check the number of participants, duration, comparison group, conflicts of interest, and whether the study measured clinical changes as well as biomarkers.
Make decisions proportionate to evidence
A testing service should explain exactly what the result can and cannot tell you. If an expensive intervention promises a biological-age reset based on a single number, ask for independent evidence of patient-relevant benefits and harms. Uncertainty is not evidence that nothing works; it is a reason to avoid oversized claims.
A practical example
For example, a supplement trial might show a statistically detectable rise in a laboratory NAD-related marker. The result could be scientifically interesting and warrant further work. But it does not follow that participants gained years of healthy life or performed better on cognitive tests. Those are different endpoints. A reputable seller should describe the measured outcome as measured, identify the study population, and acknowledge what the study did not establish. If a marketing infographic merges results from cells, mice and humans into one promise, separate those sources before drawing a conclusion. A biomarker is information, not a clinical victory by itself.
Questions worth writing down
- Which provider or qualified professional can verify know which specimen was measured?
- Which provider or qualified professional can verify distinguish biomarkers from meaningful outcomes?
- Which provider or qualified professional can verify examine the study population?
- Which provider or qualified professional can verify make decisions proportionate to evidence?
- Which facts are supported by a current primary source rather than a historical advertising claim?
- What would change the safety or value decision for the actual person involved?
Make the next decision easier
Treat the marketing claim as a testable question, not an established result. A biochemical mechanism, an attractive testimonial and a supplier certificate describe different kinds of evidence. Meaningful human outcomes, product quality, safety and total cost all deserve separate scrutiny before a consumer acts.
Start with information that can be verified: the responsible clinical or pharmacy entity where applicable, the stated evidence, and the written cost or safety details. Record what is still unknown rather than filling gaps with assumptions or a promotional headline.